BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23856652)

  • 1. The substrate and ablation of ventricular tachycardia in patients with nonischemic cardiomyopathy.
    Liuba I; Marchlinski FE
    Circ J; 2013; 77(8):1957-66. PubMed ID: 23856652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary approach to catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy.
    Kattel S; Enriquez AD
    J Interv Card Electrophysiol; 2023 Apr; 66(3):793-805. PubMed ID: 36056222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in ablation of ventricular tachycardia in nonischemic cardiomyopathy.
    Mathuria N; Tung R; Shivkumar K
    Curr Cardiol Rep; 2012 Oct; 14(5):577-83. PubMed ID: 22843484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial ventricular tachycardia substrate visualized by magnetic resonance imaging: need for a transpericardial ablation approach?
    Reithmann C; Herkommer B; Fiek M
    Clin Res Cardiol; 2016 Oct; 105(10):827-37. PubMed ID: 27294860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy with near-normal left ventricular ejection fraction.
    Bennett RG; Campbell T; Kotake Y; Turnbull S; Kumar S
    Heart Rhythm; 2022 Jan; 19(1):51-60. PubMed ID: 34597769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of simultaneous unipolar radiofrequency catheter ablation for intramural septal ventricular tachycardia in nonischemic cardiomyopathy.
    Yang J; Liang J; Shirai Y; Muser D; Garcia FC; Callans DJ; Marchlinski FE; Santangeli P
    Heart Rhythm; 2019 Jun; 16(6):863-870. PubMed ID: 30576879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter Ablation of VT in Non-Ischaemic Cardiomyopathies: Endocardial, Epicardial and Intramural Approaches.
    Bhaskaran A; Tung R; Stevenson WG; Kumar S
    Heart Lung Circ; 2019 Jan; 28(1):84-101. PubMed ID: 30385114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review.
    Wissner E; Stevenson WG; Kuck KH
    Eur Heart J; 2012 Jun; 33(12):1440-50. PubMed ID: 22411192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of ventricular tachycardia in patients with nonischemic cardiomyopathy.
    Bogun F; Morady F
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1227-30. PubMed ID: 18691235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study.
    Vaseghi M; Hu TY; Tung R; Vergara P; Frankel DS; Di Biase L; Tedrow UB; Gornbein JA; Yu R; Mathuria N; Nakahara S; Tzou WS; Sauer WH; Burkhardt JD; Tholakanahalli VN; Dickfeld TM; Weiss JP; Bunch TJ; Reddy M; Callans DJ; Lakkireddy DR; Natale A; Marchlinski FE; Stevenson WG; Della Bella P; Shivkumar K
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1141-1150. PubMed ID: 30236386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.
    Okubo K; Gigli L; Trevisi N; Foppoli L; Radinovic A; Bisceglia C; Frontera A; D'Angelo G; Cireddu M; Paglino G; Mazzone P; Della Bella P
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008307. PubMed ID: 32657137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
    Koplan BA; Soejima K; Baughman K; Epstein LM; Stevenson WG
    Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy.
    Cano O; Hutchinson M; Lin D; Garcia F; Zado E; Bala R; Riley M; Cooper J; Dixit S; Gerstenfeld E; Callans D; Marchlinski FE
    J Am Coll Cardiol; 2009 Aug; 54(9):799-808. PubMed ID: 19695457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the phrenic nerve course within the epicardial substrate of patients with nonischemic cardiomyopathy and ventricular tachycardia.
    Fan R; Cano O; Ho SY; Bala R; Callans DJ; Dixit S; Garcia F; Gerstenfeld EP; Hutchinson M; Lin D; Riley M; Marchlinski FE
    Heart Rhythm; 2009 Jan; 6(1):59-64. PubMed ID: 19121801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia.
    Yamashita S; Sacher F; Mahida S; Berte B; Lim HS; Komatsu Y; Amraoui S; Denis A; Derval N; Laurent F; Sermesant M; Montaudon M; Hocini M; Haïssaguerre M; Jaïs P; Cochet H
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):699-708. PubMed ID: 26918883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocardial substrate mapping for monomorphic ventricular tachycardia ablation in ischemic and non-ischemic cardiomyopathy.
    Fukuzawa K; Yoshida A; Kubo S; Takano T; Kiuchi K; Kanda G; Takami K; Kumagai H; Torii S; Takami M; Yokoyama M; Hirata K
    Kobe J Med Sci; 2008 Jul; 54(2):E122-35. PubMed ID: 18772614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial.
    Di Biase L; Burkhardt JD; Lakkireddy D; Carbucicchio C; Mohanty S; Mohanty P; Trivedi C; Santangeli P; Bai R; Forleo G; Horton R; Bailey S; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Pelargonio G; Hongo RH; Beheiry S; Hao SC; Reddy M; Rossillo A; Themistoclakis S; Dello Russo A; Casella M; Tondo C; Natale A
    J Am Coll Cardiol; 2015 Dec; 66(25):2872-2882. PubMed ID: 26718674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation of ventricular tachycardia in nonischemic heart disease.
    Tokuda M; Tedrow UB; Kojodjojo P; Inada K; Koplan BA; Michaud GF; John RM; Epstein LM; Stevenson WG
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):992-1000. PubMed ID: 22942218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.